Justice Department Notices — 2026-11-05

Estimated reading time: 3 minutes

1. United States, et al. v. OhioHealth Corporation; Amended Response to Public Comments on the Proposed Final Judgment

Link: https://www.federalregister.gov/documents/2026/11/05/2026-22618/united-states-et-al-v-ohiohealth-corporation-amended-response-to-public-comments-on-the-proposed

Sub: Justice Department, Antitrust Division

2. Bulk Manufacturer of Controlled Substances Application: Navinta LLC

Link: https://www.federalregister.gov/documents/2026/11/05/2026-22556/bulk-manufacturer-of-controlled-substances-application-navinta-llc

Sub: Justice Department, Drug Enforcement Administration

Content: Navinta LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

3. Importer of Controlled Substances Application: Diamond Animal Health, Inc.

Link: https://www.federalregister.gov/documents/2026/11/05/2026-22555/importer-of-controlled-substances-application-diamond-animal-health-inc

Sub: Justice Department, Drug Enforcement Administration

Content: Diamond Animal Health, Inc., has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

4. Importer of Controlled Substances Application: Noramco

Link: https://www.federalregister.gov/documents/2026/11/05/2026-22553/importer-of-controlled-substances-application-noramco

Sub: Justice Department, Drug Enforcement Administration

Content: Noramco has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.


Legal Disclaimer

This article includes content collected from the Federal Register (federalregister.gov). The content is not an official government publication. This article is for informational purposes only and does not constitute legal advice. For case-specific consultation, please contact us. Read our full Legal Disclaimer, which also includes information on translation accuracy.